关于 Ruxolitinib phosphate
- 原研厂家
- Incyte Corp
- 适应症
- Graft-Versus-Host Disease (GVHD); Vitiligo; Atopic Dermatitis; Myelofibrosis; Polycythemia Vera
- 获批日期
- 12/01/2011
- DS/DP
- 12/24/2027
可供应中间体
当前列出 Ruxolitinib phosphate 的 18 个中间体。可就下方任一产品索取规格、文件或报价。
| 产品名称 | CAS 号 | 分子式 | 物理性质 |
|---|---|---|---|
| 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 1029716-44-6 | / | / |
| -CYCLOPENTYLACRYLONITRILE | 591769-05-0 | / | / |
| Cyclopentanecarbaldehyde | 872-53-7 | / | / |
| 4-Chloropyrrolo[2,3-d]pyrimidine | 3680-69-1 | / | / |
| 4-(1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine | 941685-27-4 | / | / |
| 3-cyclopentyl-3-[4-(7-[2-(trimethylsilyl)ethoxy]methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile | 941685-39-8 | / | / |
| (3R)-3-cyclopentyl-3-[4-(7-[2-(trimethylsilyl)ethoxy]methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile | 941685-40-1 | / | / |
| (S)-3-cyclopentyl-3-hydrazinylpropanenitrile L-tartaric acid salt dihydrate | 2761879-36-9 | / | / |
| 2-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)acetic acid | 1000518-93-3 | / | / |
| 4-methyl-7H-pyrrolo[2,3-d]pyrimidine | 945950-37-8 | / | / |
| (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | 41678-49-5 | / | / |
| (4-(1-(2-Cyano-1-cyclopentylethyl)-1h-pyrazol-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | 1236033-05-8 | / | / |
| 4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE | 941685-26-3 | / | / |
| 1H-Pyrazole-1-propanamide, 4-bromo-β-cyclopentyl-, (βR)- | 2201066-06-8 | / | / |
| (R)-3-(4-broMo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | 1146629-83-5 | / | / |
| (R)-3-cyclopentyl-3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile | 1146629-84-6 | / | / |
| 3-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile | 1153949-38-2 | / | / |
| (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | 1146629-75-5 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →